ConductScience.org, home

Paper357745

Angiogenesis and oncogenesis.

Gullino PM. J Natl Cancer Inst, 1978. Cited by 94 papers, by iCite.

Cite this record

ConductScience Library. Angiogenesis and oncogenesis. Papers, record 357745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/357745

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Angiogenesis and oncogenesis.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
2.13
iCite
Revised in PubMed
2004-11-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gullino PMP M

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiogenesis Inducing AgentsMajor topic
Growth SubstancesMajor topic
NeoplasmsMajor topic
Animals
Breast Neoplasms
Cell Transformation, Neoplastic
Female
Humans
Male
Mammary Neoplasms, Experimental
Precancerous Conditions

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
34552183The development of tumour vascular networks.Commun Biol2021https://conductscience.org/library/papers/34552183PubMed
31966483CCL4 promotes the cell proliferation, invasion and migration of endometrial carcinoma by targeting the VEGF-A signal pathway.Int J Clin Exp Pathol2017https://conductscience.org/library/papers/31966483PubMed
27823583Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation.Elife2016https://conductscience.org/library/papers/27823583PubMed
26918726Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors.Oncotarget2016https://conductscience.org/library/papers/26918726PubMed
26456697Novel anticancer agent, SQAP, binds to focal adhesion kinase and modulates its activity.Sci Rep2015https://conductscience.org/library/papers/26456697PubMed
26000022Combined effects of pericytes in the tumor microenvironment.Stem Cells Int2015https://conductscience.org/library/papers/26000022PubMed
25363007Antiangiogenic therapies for glioblastoma.CNS Oncol2014https://conductscience.org/library/papers/25363007PubMed
24740542Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth.Am J Physiol Cell Physiol2014https://conductscience.org/library/papers/24740542PubMed
24263574Trace element inhibition of carcinogenesis and angiogenesis.Biol Trace Elem Res1983https://conductscience.org/library/papers/24263574PubMed
22720169The Roles of Angiogenesis in Malignant Melanoma: Trends in Basic Science Research over the Last 100 Years.ISRN Oncol2012https://conductscience.org/library/papers/22720169PubMed
21742796Normalization of the vasculature for treatment of cancer and other diseases.Physiol Rev2011https://conductscience.org/library/papers/21742796PubMed
16870537Inhibitors of angiogenesis.Clin Transl Oncol2006https://conductscience.org/library/papers/16870537PubMed
11964252
Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactions affects protein folding.
Biophys J2002https://conductscience.org/library/papers/11964252PubMed
11381144Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11381144PubMed
10935474Causes and effects of heterogeneous perfusion in tumors.Neoplasia1999https://conductscience.org/library/papers/10935474PubMed
9675169
Nature of interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(Carbonyl-bis[imino-N-methyl-4, 2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino] )bis-(1, 3-naphthalene disulfonate).
Biophys J1998https://conductscience.org/library/papers/9675169PubMed
7781141Antitumor activity of FCE 26644 a new growth-factor complexing molecule.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7781141PubMed
7582244A quantitative investigation of immunocytochemically stained blood vessels in normal, benign, premalignant and malignant human oral cheek epithelium.Virchows Arch1995https://conductscience.org/library/papers/7582244PubMed
6388825Invasiveness of transformed bladder epithelial cells.Cancer Metastasis Rev1984https://conductscience.org/library/papers/6388825PubMed
6370420Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.Cancer Metastasis Rev1984https://conductscience.org/library/papers/6370420PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/357745

GET https://conductscience.org/api/papers/v1/357745/cited_by?page=2